Skip to main content
Caplight Logo









SynGenSys

SynGenSys

Private
SheffieldHealthcare & Life Scienceshttps://www.syngensys.com/

Last Round

Seed

Apr 1, 2025

Total Funding Raised

$4.09M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

SynGenSys is a biotechnology company that designs synthetic gene promoter systems to address bottlenecks in biopharma manufacturing and enhance cell and gene therapy development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

synthetic biologysynthetic gene promotersgene expression controlcell and gene therapyCGTpromoter engineeringgenerative biologycomputational design platformpromoter librarybiomanufacturingcustom promoter designgenetic circuit designbio-foundrytissue-specific expression

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SynGenSys Comparables

Compare SynGenSys with similar companies based on industry and business-model similarity.

SynGenSys comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chromatin Bioscience
92%
Concinnity Genetics
82%
Annogen
81%

SynGenSys Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 1, 2025
SeedApr 3, 2024

SynGenSys Investors

Notable investors and investment history

SynGenSys investors
InvestorRounds
UKRI Innovate UKSeed
Takeda VenturesSeed
The University of SheffieldSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 106% MoM, reaching 3.1K.

  • Jul 20, 2026

    Open roles increased to 5, 2.1x the trailing average.

SynGenSys Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SynGenSys Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SynGenSys's valuation, stock price, and market status.

Firmographic Details

HeadquartersSheffield
Employee Range18
Year Founded2021
Last FundingApr 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?